GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASEP Medical Holdings Inc (OTCPK:SEPSF) » Definitions » Net Change in Cash

ASEP Medical Holdings (ASEP Medical Holdings) Net Change in Cash : $-1.63 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ASEP Medical Holdings Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

ASEP Medical Holdings's Net Change in Cash for the three months ended in Mar. 2024 was $-0.03 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.63 Mil.

ASEP Medical Holdings Net Change in Cash Historical Data

The historical data trend for ASEP Medical Holdings's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASEP Medical Holdings Net Change in Cash Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23
Net Change in Cash
4.13 -2.33 -1.54

ASEP Medical Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.42 -0.51 -0.50 -0.59 -0.03

ASEP Medical Holdings Net Change in Cash Calculation

ASEP Medical Holdings's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-2.022+-0.003+0.485+0
=-1.54

ASEP Medical Holdings's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.104+0+0.07+0
=-0.03

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASEP Medical Holdings Net Change in Cash Related Terms

Thank you for viewing the detailed overview of ASEP Medical Holdings's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

ASEP Medical Holdings (ASEP Medical Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASEP Medical Holdings Inc (OTCPK:SEPSF) » Definitions » Net Change in Cash
Comparable Companies
XCNQ:MDMA XCNQ:PHRM XCNQ:COOL TSXV:QPT XCNQ:TELI TSX:AEZS XCNQ:BLAB NEOE:BMND TSXV:NRX TSXV:KNE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
JJ8:Germany ASEP:Canada
Address
730 View Street, Suite 420, Victoria, BC, CAN, V8W 3Y7
Website
https://www.asepmedical.com
ASEP Medical Holdings Inc is a biotechnology firm pursuing the commercialization of broad-spectrum peptide technology. The Company is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine and is engaged in the business of acquiring research and development assets, technology, or businesses in life sciences and medical diagnostics.

ASEP Medical Holdings (ASEP Medical Holdings) Headlines

From GuruFocus

Asep Inc. Founder, Chair and CEO, Dr. Robert E. W. Hancock, Ranked 4th Best Microbiologist in the World

By PRNewswire PRNewswire • 06-20-2023

Asep Medical Inc. Announces Allowance of European Patent for First-Generation Sepsis Diagnostic Technology (SepsetER)

By PRNewswire PRNewswire • 07-13-2022

Asep Medical Holdings Inc. Achieves Significant Milestones Addressing Antibiotic Failure Through Proprietary Diagnostic & Therapeutic Technologies

By PRNewswire PRNewswire • 12-23-2022

Asep Inc. Obtains Exclusive Worldwide License from the University of British Columbia for Ground-breaking Medical Device Coating Technology

By PRNewswire • 08-02-2023

Asep Inc. is Granted Patent Approval for its Sepsis Diagnostic Technology in 13 European Countries and Australia

By PRNewswire PRNewswire • 11-07-2022

ASEP INC. ANNOUNCES CLOSING OF DEBT SETTLEMENT

By PRNewswire • 12-29-2023

Asep Inc. Signs Definitive Agreement for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa

By PRNewswire PRNewswire • 06-10-2023

Asep Medical Holdings Inc. Taking Actions for Revocation of Cease Trade Order

By PRNewswire PRNewswire • 06-30-2022

Asep Inc. Engages Aegis Capital Corporation for Listing on NASDAQ Stock Exchange

By PRNewswire PRNewswire • 05-31-2023

Asep Medical Holdings Inc. Receives Revocation of Cease Trade Order from the BC Securities Commission

By PRNewswire PRNewswire • 07-07-2022